We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$412M
1-Year Est. Return
18.33%
This Fund
S&P 500
This Quarter
Est. Return
-0.64%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$1.33B
AUM Growth
-$191M
(-13%)
Cap. Flow
-$172M
Cap. Flow
% of AUM
-12.94%
Top 10 Holdings %
Top 10 Hldgs %
28.25%
Holding
397
New
37
Increased
97
Reduced
153
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advance Auto Parts
AAP
|
+$15M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$14M |
| 3 |
Kroger
KR
|
+$12.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$12.1M |
| 5 |
First Citizens BancShares
FCNCA
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kimberly-Clark
KMB
|
+$21.8M |
| 2 |
Quest Diagnostics
DGX
|
+$15M |
| 3 |
Dollar Tree
DLTR
|
+$12.5M |
| 4 |
Biogen
BIIB
|
+$10.8M |
| 5 |
Gen Digital
GEN
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.61% |
| 2 | Consumer Staples | 24.84% |
| 3 | Technology | 8.65% |
| 4 | Financials | 6.98% |
| 5 | Communication Services | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$376B
| $40.9M | 3.08% |
354,148
-62,424
| -15% | -$7.09M |
|
|
K
2
DELISTED
Kellanova
K
| $38.4M | 2.89% |
606,082
-69,854
| -10% | -$4.45M |
|
3
General Mills
GIS
$21B
| $38M | 2.86% |
494,966
-35,173
| -7% | -$3.01M |
|
4
Pfizer
PFE
$164B
| $37.9M | 2.86% |
1,032,663
-35,284
| -3% | -$1.37M |
|
5
Clorox
CLX
$11.4B
| $37.8M | 2.85% |
237,975
-33,367
| -12% | -$5.38M |
|
6
AbbVie
ABBV
$460B
| $37.4M | 2.82% |
277,792
+57,004
| +26% | +$8.36M |
|
7
Church & Dwight Co
CHD
$23.4B
| $36.8M | 2.77% |
366,994
-95,016
| -21% | -$8.95M |
|
8
Johnson & Johnson
JNJ
$671B
| $36.7M | 2.77% |
221,793
-5,145
| -2% | -$830K |
|
9
Bristol-Myers Squibb
BMY
$139B
| $36.4M | 2.75% |
569,913
-19,661
| -3% | -$1.32M |
|
10
Newmont
NEM
$137B
| $34.4M | 2.6% |
806,989
+93,395
| +13% | +$4.24M |
|
11
United Therapeutics
UTHR
$21B
| $32.8M | 2.47% |
148,493
-21,430
| -13% | -$4.75M |
|
12
Take-Two Interactive
TTWO
$40B
| $32.6M | 2.46% |
221,455
-72,342
| -25% | -$9.46M |
|
13
J.M. Smucker
SJM
$13.7B
| $31M | 2.34% |
210,258
-18,268
| -8% | -$2.79M |
|
|
14
Kroger
KR
$35.8B
| $29.7M | 2.24% |
631,391
+255,022
| +68% | +$12.2M |
|
15
Neurocrine Biosciences
NBIX
$16.1B
| $29.4M | 2.22% |
311,715
-50,689
| -14% | -$4.95M |
|
|
16
Gen Digital
GEN
$18.8B
| $29.1M | 2.2% |
1,569,525
-599,761
| -28% | -$10.5M |
|
17
Campbell Soup
CPB
$6.6B
| $29.1M | 2.19% |
636,579
-103,441
| -14% | -$5.33M |
|
18
Humana
HUM
$48.8B
| $27.1M | 2.04% |
60,566
-7,155
| -11% | -$3.6M |
|
19
C.H. Robinson
CHRW
$17.1B
| $26M | 1.96% |
275,113
-60,585
| -18% | -$5.86M |
|
20
Hormel Foods
HRL
$11.9B
| $25.1M | 1.89% |
623,370
-161,764
| -21% | -$6.49M |
|
21
SLB Ltd
SLB
$85.2B
| $23.8M | 1.79% |
484,554
-60,835
| -11% | -$2.9M |
|
22
First Solar
FSLR
$22.3B
| $22.7M | 1.71% |
119,359
+22,701
| +23% | +$4.5M |
|
23
Hershey
HSY
$35.2B
| $21.8M | 1.64% |
87,158
+7,802
| +10% | +$2.05M |
|
24
Assurant
AIZ
$14.2B
| $21.2M | 1.6% |
168,936
-33,756
| -17% | -$4.2M |
|
25
McKesson
MCK
$107B
| $21.2M | 1.6% |
49,587
+5,916
| +14% | +$2.27M |
|
Similar funds
EC
WIP
KP
MP
AWP
THCM
PA
HP
TOBAM's Q2 2023 Portfolio in Review
As of Q2 2023, TOBAM held 397 positions worth $1.33B, down 13% from $1.52B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
TOBAM withdrew a net $172M in Q2 2023, closing 38 positions and reducing 153 holdings. Its most notable exit was argenx, an estimated $2.75M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, TOBAM opened a new position in Advance Auto Parts worth $10.2M.
- TOBAM's largest Q2 2023 buy was Advance Auto Parts: 145,601 shares worth $10.2M.
- TOBAM added most to Kroger in Q2 2023, an estimated $12.2M increase.
- TOBAM's biggest Q2 2023 reduction was Kimberly-Clark, cutting an estimated $21.8M.
- TOBAM fully exited argenx in Q2 2023, selling an estimated $2.75M.
- TOBAM's ten largest holdings make up 28% of its $1.33B portfolio in Q2 2023.
- TOBAM opened 37 new positions and closed 38 in Q2 2023.
- TOBAM's portfolio value fell 13% quarter-over-quarter to $1.33B.
Based on TOBAM's 13F filing for Q2 2023, filed 31 Jul 2023.